Log in to save to my catalogue

Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomiz...

Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomiz...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e6a75dffe6ea4d42929cd2bcbf27e991

Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials

About this item

Full title

Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-01, Vol.11 (1), p.452-452, Article 452

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various cardiovascular diseases. However, the potential for asthma exacerbation is one of the major adverse effects of beta-blockers. This study aimed to compare the level of risk for an asthma attack in patients receiving various beta-blockers. We searched f...

Alternative Titles

Full title

Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e6a75dffe6ea4d42929cd2bcbf27e991

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e6a75dffe6ea4d42929cd2bcbf27e991

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-020-79837-3

How to access this item